Vertex
The Director, Deal Assessment - Payer leads payer and PBM deal assessment within US Market Access, delivering on contracting strategy across the Vertex portfolio. This role translates account and financial analytics into strategic contracting decisions, engaging directly with external accounts and presenting recommendations to senior leadership. The position connects payer and PBM account decisions to portfolio net price strategy, bringing analytical rigor and clear strategic ownership to contracting opportunities.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1989
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vertex.
Bamco Inc. NY Trims Stake in Vertex Pharmaceuticals
1 day ago
Associate Director, Pricing Strategy & Access Analytics
Amylyx Pharmaceuticals
Senior Director, Head of Payer Strategy & Engagement
Capricor Therapeutics
Contracts & Pricing Strategy, Associate Director
Amgen
Director, Managed Care Payer Contracting
Insulet
Director of Market Access Payer Account
Summit Therapeutics,
Vice President, Market Access
Mirum Pharmaceuticals